Annual report [Section 13 and 15(d), not S-K Item 405]

Financial Instruments - Summary Of Changes In Level One and Level Three Financial Assets (Details)

v3.25.1
Financial Instruments - Summary Of Changes In Level One and Level Three Financial Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loss on equity method investments $ (211) $ (183)
4 Front Venture Corp.    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 56 130
Additions 0 0
Revaluations (46) (74)
Loss on equity method investments 0 0
Ending balance 10 56
Other Long-term Investments [Member] | The Pharm Stand, LLC    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 0 0
Additions 125 0
Revaluations 0 0
Loss on equity method investments 0 0
Ending balance 125 0
Other Long-term Investments [Member] | Island Thyme LLC    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 679 102
Additions 260 760
Revaluations 0 0
Loss on equity method investments (211) (183)
Ending balance $ 728 $ 679